PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RCEL vs. O
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RCEL and O is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

RCEL vs. O - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AVITA Medical, Inc. (RCEL) and Realty Income Corporation (O). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
-16.76%
-2.39%
RCEL
O

Key characteristics

Sharpe Ratio

RCEL:

-0.52

O:

0.06

Sortino Ratio

RCEL:

-0.31

O:

0.20

Omega Ratio

RCEL:

0.95

O:

1.02

Calmar Ratio

RCEL:

-0.44

O:

0.04

Martin Ratio

RCEL:

-0.93

O:

0.13

Ulcer Index

RCEL:

40.60%

O:

7.35%

Daily Std Dev

RCEL:

72.95%

O:

17.33%

Max Drawdown

RCEL:

-91.79%

O:

-48.45%

Current Drawdown

RCEL:

-84.33%

O:

-16.88%

Fundamentals

Market Cap

RCEL:

$226.78M

O:

$47.80B

EPS

RCEL:

-$2.23

O:

$1.05

Total Revenue (TTM)

RCEL:

$45.85M

O:

$3.95B

Gross Profit (TTM)

RCEL:

$39.03M

O:

$2.48B

Returns By Period

In the year-to-date period, RCEL achieves a -32.42% return, which is significantly lower than O's 2.77% return.


RCEL

YTD

-32.42%

1M

-26.51%

6M

-12.71%

1Y

-37.81%

5Y*

-28.93%

10Y*

N/A

O

YTD

2.77%

1M

3.98%

6M

-2.51%

1Y

2.21%

5Y*

-1.37%

10Y*

5.23%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RCEL vs. O — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RCEL
The Risk-Adjusted Performance Rank of RCEL is 2222
Overall Rank
The Sharpe Ratio Rank of RCEL is 1919
Sharpe Ratio Rank
The Sortino Ratio Rank of RCEL is 2323
Sortino Ratio Rank
The Omega Ratio Rank of RCEL is 2222
Omega Ratio Rank
The Calmar Ratio Rank of RCEL is 2020
Calmar Ratio Rank
The Martin Ratio Rank of RCEL is 2525
Martin Ratio Rank

O
The Risk-Adjusted Performance Rank of O is 4343
Overall Rank
The Sharpe Ratio Rank of O is 4747
Sharpe Ratio Rank
The Sortino Ratio Rank of O is 3636
Sortino Ratio Rank
The Omega Ratio Rank of O is 3636
Omega Ratio Rank
The Calmar Ratio Rank of O is 4747
Calmar Ratio Rank
The Martin Ratio Rank of O is 4747
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RCEL vs. O - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AVITA Medical, Inc. (RCEL) and Realty Income Corporation (O). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for RCEL, currently valued at -0.52, compared to the broader market-2.000.002.004.00-0.520.06
The chart of Sortino ratio for RCEL, currently valued at -0.31, compared to the broader market-4.00-2.000.002.004.006.00-0.310.20
The chart of Omega ratio for RCEL, currently valued at 0.95, compared to the broader market0.501.001.502.000.951.02
The chart of Calmar ratio for RCEL, currently valued at -0.44, compared to the broader market0.002.004.006.00-0.440.04
The chart of Martin ratio for RCEL, currently valued at -0.93, compared to the broader market-10.000.0010.0020.0030.00-0.930.13
RCEL
O

The current RCEL Sharpe Ratio is -0.52, which is lower than the O Sharpe Ratio of 0.06. The chart below compares the historical Sharpe Ratios of RCEL and O, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50AugustSeptemberOctoberNovemberDecember2025
-0.52
0.06
RCEL
O

Dividends

RCEL vs. O - Dividend Comparison

RCEL has not paid dividends to shareholders, while O's dividend yield for the trailing twelve months is around 5.74%.


TTM20242023202220212020201920182017201620152014
RCEL
AVITA Medical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
O
Realty Income Corporation
5.74%5.38%5.33%4.69%3.88%4.51%3.69%4.19%4.45%4.19%4.42%4.59%

Drawdowns

RCEL vs. O - Drawdown Comparison

The maximum RCEL drawdown since its inception was -91.79%, which is greater than O's maximum drawdown of -48.45%. Use the drawdown chart below to compare losses from any high point for RCEL and O. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-84.33%
-16.88%
RCEL
O

Volatility

RCEL vs. O - Volatility Comparison

AVITA Medical, Inc. (RCEL) has a higher volatility of 48.46% compared to Realty Income Corporation (O) at 6.34%. This indicates that RCEL's price experiences larger fluctuations and is considered to be riskier than O based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%AugustSeptemberOctoberNovemberDecember2025
48.46%
6.34%
RCEL
O

Financials

RCEL vs. O - Financials Comparison

This section allows you to compare key financial metrics between AVITA Medical, Inc. and Realty Income Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab